Post-Roe Isn’t Over: What the Supreme Court Is Deciding Right Now

In 2022, the United States Supreme Court overturned Roe v. Wade, ending the federal constitutional right to abortion. But the legal fight did not end there.

This series explains two major cases currently before the Supreme Court that could further reshape abortion access across the country. The first case challenges the FDA’s approval and regulation of mifepristone, the most commonly used abortion pill. The second questions whether hospitals in states with abortion bans must still provide emergency abortion care under federal law.

Both cases have national implications. Their outcomes could affect access to care, mail-order medication, emergency treatment, and the limits of state and federal authority.

This series breaks down what the Court is deciding, why it matters, and how to stay informed and engaged. All information is sourced from verified, nonpartisan, and fact-based organizations.

These decisions are expected in June 2025. Until then, the future of reproductive rights remains uncertain and active.


Cited Sources:

  1. SCOTUSblog
    https://www.scotusblog.com

  2. Supreme Court of the United States (Official Site)
    https://www.supremecourt.gov

  3. National Public Radio (NPR)
    https://www.npr.org

  4. Associated Press (AP News)
    https://apnews.com

  5. Reuters
    https://www.reuters.com

  6. U.S. Department of Health and Human Services (HHS)
    https://www.hhs.gov

  7. KFF (Kaiser Family Foundation)
    https://www.kff.org

  8. Guttmacher Institute
    https://www.guttmacher.org

  9. American Civil Liberties Union (ACLU)
    https://www.aclu.org

  10. Center for Reproductive Rights
    https://reproductiverights.org


Case Summaries:

  1. Mifepristone Access (FDA v. Alliance for Hippocratic Medicine)

  2. Emergency Abortion Care (Moyle v. United States / Idaho v. United States)

Cited Sources:

Mifepristone Access – FDA v. Alliance for Hippocratic Medicine

  • SCOTUSblog – Case overview

    • 🔗https://www.scotusblog.com/case-files/cases/fda-v-alliance-for-hippocratic-medicine/

  • NPR – Abortion pill case explained

    • 🔗 https://www.npr.org/2024/03/26/1240549161/scotus-mifepristone-abortion-pill

  • KFF – Medication abortion data and policy

    • 🔗 https://www.kff.org/womens-health-policy/fact-sheet/medication-abortion/

  • FDA – Official mifepristone info

    • 🔗https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/mifepristone-mifeprex-information

Emergency Abortion Care – Moyle v. United States / Idaho v. United States

  • SCOTUSblog – EMTALA case preview

    • 🔗 https://www.scotusblog.com/case-files/cases/moyle-v-united-states/

  • HHS – EMTALA and abortion care guidance (July 2022)

    • 🔗https://www.hhs.gov/about/news/2022/07/11/hhs-takes-action-to-protect-patients-in-emergency-situations.html

  • AP News – Supreme Court to weigh emergency abortion care

    • 🔗https://apnews.com/article/supreme-court-abortion-idaho-emtala-2024-04-16-0c8822897cf27c7f361e089dfe20e88a

  • Center for Reproductive Rights – Case explainer

    • 🔗 https://reproductiverights.org/cases/moyle-v-united-states/

Next
Next

Presidential Power: How Far Can It Go?